Matinas BioPharma Holdings, Inc. (MTNB): Going concern doubt
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
lents on hand are sufficient to fund planned operations for a period of at least twelve months from the filing date of these financial statements. As a result, substantial doubt exists about the Company’s ability to continue as a going concern.
Why it matters
A going-concern disclosure reflects substantial doubt about the company's ability to continue operating.